NASDAQ:ASNS Arsanis (ASNS) Stock Price, News & Analysis → Tim Sykes’ Urgent Trade Alert: “Make this move now” (From Timothy Sykes) (Ad) Free ASNS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$0.36▼$0.5550-Day Range$3.11▼$3.1152-Week Range$1.15▼$28.69Volume942,474 shsAverage Volume958,680 shsMarket Capitalization$1.83 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisCompetitorsEarningsHeadlinesInsider TradesShort InterestTrendsStock AnalysisCompetitorsEarningsHeadlinesInsider TradesShort InterestTrends Get Arsanis alerts: Email Address Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry About Arsanis Stock (NASDAQ:ASNS)X4 Pharmaceuticals, Inc. operates as a biotechnology company, which engages in developing human antibodies for treating infectious diseases. The company focuses on restoring healthy immune system function by developing novel therapeutics for the treatment of rare diseases. Its products in pipeline include X4P-001, X4P-002, and X4P-003. The company was founded by Henri A. Termeer, Keith T. Flaherty, Renato T. Skerlj, Richard Peters and Paula Ragan and is headquartered in Cambridge, MA.Read More Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry ASNS Stock News HeadlinesMay 23, 2024 | globenewswire.comActelis Networks Signs Binding Term Sheet to Acquire Quality Industrial Corporation and Expand Operations in Critical Energy IndustryMay 14, 2024 | finance.yahoo.comActelis Networks Reports Fiscal First Quarter 2024May 14, 2024 | globenewswire.comActelis Networks Reports Fiscal First Quarter 2024May 6, 2024 | globenewswire.comActelis Receives Order and Delivers Instant, Secure Fiber-Grade Networking to Modernize City of Bakersfield, CaliforniaMay 2, 2024 | finance.yahoo.comActelis Receives $2.3 Million Order for Immediate Delivery of New Hybrid-Fiber Intelligent Networking Solution For Washington D.C.’s Department of TransportationMay 2, 2024 | globenewswire.comActelis Receives $2.3 Million Order for Immediate Delivery of New Hybrid-Fiber Intelligent Networking Solution For Washington D.C.'s Department of TransportationApril 4, 2024 | globenewswire.comActelis Networks and Khushi Communications Partner to Enable Expansion of IoT Networks Throughout IndiaMarch 26, 2024 | globenewswire.comActelis Networks Reports Fiscal Full Year 2023 ResultsMarch 12, 2024 | finance.yahoo.comActelis Networks and Netceed Sign Partnership Agreement to Extend Actelis’ Hybrid-Fiber Networking Solutions to Netceed’s North American Customer BaseFebruary 29, 2024 | globenewswire.comActelis Achieves National Institute of Standards and Technology (NIST) Certification for Data Cyber SecurityFebruary 7, 2024 | finance.yahoo.comActelis Networks Announces New $1.5 Million Credit LineFebruary 1, 2024 | finance.yahoo.comActelis Receives Order For City of Napa Intelligent Traffic Management SystemJanuary 16, 2024 | finance.yahoo.comActelis Announces U.S. Department of Defense JITC Labs Approval for Cybersecurity and Interoperability and Approved Products List StatusDecember 28, 2023 | finance.yahoo.comActelis Receives Order From Major North American Rail Operator For Management Software And ServicesDecember 20, 2023 | finance.yahoo.comActelis Networks Announces Closing of $1.5 Million Private Placement Priced At-The-Market Under Nasdaq RulesDecember 18, 2023 | finance.yahoo.comActelis Networks Announces $1.5 Million Private Placement Priced At-The-Market Under Nasdaq RulesDecember 14, 2023 | finance.yahoo.comActelis Announces Order Received and Launch of New Last Mile Hybrid-Fiber Multi-Gigabit Broadband Solution For Buildings and IoT ApplicationsDecember 7, 2023 | morningstar.comActelis Networks Inc ASNSDecember 6, 2023 | finance.yahoo.comActelis Receives Order For Networking Of Traffic Management and Safety IoT Applications In The City of Everett, WashingtonNovember 29, 2023 | finance.yahoo.comActelis Receives Order From Major German Energy Provider For Encrypted, Cyber-Hardened, Hybrid-Fiber NetworkingNovember 20, 2023 | finance.yahoo.comActelis Delivers Hybrid-Fiber Networking Solutions to US Naval Base In Asia-PacificNovember 14, 2023 | finance.yahoo.comActelis Networks Reports Third Quarter 2023October 24, 2023 | finance.yahoo.comActelis Launches Unique, Ultra Low Power In-Building Gigabit Connectivity Solution For Instant Service Provisioning of Multi-Tenant UnitsOctober 17, 2023 | finance.yahoo.comActelis Selected and Receives First Order to Provide IoT Networking To European Natural Gas System OperatorSeptember 27, 2023 | finance.yahoo.comActelis Achieves Third Party Validation For FIPS Cyber Protection Standard Required by Government AgenciesSee More Headlines Receive ASNS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Arsanis and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/26/2024Today5/28/2024Next Earnings (Estimated)8/22/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorComputer and Technology Industry Communications equipment, not elsewhere classified Sub-IndustryN/A Current SymbolNASDAQ:ASNS CUSIPN/A CIK1501697 Webwww.arsanis.com Phone(857) 529-8300FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)($2.17) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-6,290,000.00 Net Margins-142.22% Pretax Margin-142.22% Return on Equity-3,729.24% Return on Assets-54.89% Debt Debt-to-Equity Ratio13.77 Current Ratio0.70 Quick Ratio0.40 Sales & Book Value Annual Sales$5.61 million Price / Sales0.33 Cash FlowN/A Price / Cash FlowN/A Book Value$0.08 per share Price / Book6.81Miscellaneous Outstanding Shares3,350,000Free Float2,878,000Market Cap$1.83 million OptionableNot Optionable Beta0.87 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesPaula S. RaganPresident, Chief Executive Officer & DirectorAdam S. MostafaChief Financial Officer & TreasurerCeleste DiJohnsonVice President-Clinical OperationsMary DiBiaseVice President-Technical Operations & QualityTarek EbrahimVice President-Medical Affairs & Rare DiseaseKey CompetitorsCOMSovereignNASDAQ:COMSLytus Technologies Holdings PTV.NASDAQ:LYTRubicon TechnologyNASDAQ:RBCNSiyata MobileNASDAQ:SYTABIO-key InternationalNASDAQ:BKYIView All Competitors ASNS Stock Analysis - Frequently Asked Questions Are investors shorting Arsanis? Arsanis saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 46,200 shares, an increase of 974.4% from the April 30th total of 4,300 shares. Based on an average daily trading volume, of 304,400 shares, the days-to-cover ratio is presently 0.2 days. Currently, 1.5% of the shares of the stock are sold short. View Arsanis' Short Interest. When is Arsanis' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, August 22nd 2024. View our ASNS earnings forecast. How were Arsanis' earnings last quarter? Arsanis, Inc. (NASDAQ:ASNS) issued its quarterly earnings data on Tuesday, March, 26th. The company reported ($0.67) earnings per share (EPS) for the quarter. The firm earned $1.02 million during the quarter. Arsanis had a negative net margin of 142.22% and a negative trailing twelve-month return on equity of 3,729.24%. When did Arsanis' stock split? Arsanis's stock reverse split on Wednesday, April 19th 2023. The 1-10 reverse split was announced on Wednesday, April 19th 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, April 19th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. What other stocks do shareholders of Arsanis own? Based on aggregate information from My MarketBeat watchlists, some companies that other Arsanis investors own include Catalyst Pharmaceuticals (CPRX), NxStage Medical (NXTM), Selecta Biosciences (SELB), CDTi Advanced Materials (CDTI), Curis (CRIS), bluebird bio (BLUE), Juno Therapeutics (JUNO), Nektar Therapeutics (NKTR), Tocagen (TOCA). When did Arsanis IPO? Arsanis (ASNS) raised $15 million in an initial public offering on Friday, May 13th 2022. The company issued 3,000,000 shares at a price of $4.00-$6.00 per share. Boustead Securities acted as the underwriter for the IPO. This page (NASDAQ:ASNS) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsWARNING about the death of the U.S. dollar…Colonial MetalsThe only AI company to buyPorter & CompanyBiggest Prediction of My 50-Year Career on Wall StreetChaikin AnalyticsPresident Biden just made a shocking moveStansberry ResearchExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arsanis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
